Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes.

Lack of leptin (ob) protein causes obesity in mice. The leptin gene product is important for normal regulation of appetite and metabolic rate and is produced exclusively by adipocytes. Leptin mRNA was induced during the adipose conversion of 3T3-L1 cells, which are useful for studying adipocyte differentiation and function under controlled conditions. We studied leptin regulation by antidiabetic thiazolidinedione compounds, which are ligands for the adipocyte-specific nuclear receptor peroxisome proliferator-activated receptor gamma (PPARgamma) that regulates the transcription of other adipocyte-specific genes. Remarkably, leptin gene expression was dramatically repressed within a few hours after thiazolidinedione treatment. The ED50 for inhibition of leptin expression by the thiazolidinedione BRL49653 was between 5 and 50 nM, similar to its Kd for binding to PPARgamma. The relatively weak, nonthiazolidinedione PPAR activator WY 14,643 also inhibited leptin expression, but was approximately 1000 times less potent than BRL49653. These results indicate that antidiabetic thiazolidinediones down-regulate leptin gene expression with potencies that correlate with their abilities to bind and activate PPARgamma.

[1]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.

[2]  C. Hofmann,et al.  Antidiabetic agent pioglitazone enhances adipocyte differentiation of 3T3-F442A cells. , 1993, The American journal of physiology.

[3]  M. Lazar,et al.  Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation. , 1994, Endocrinology.

[4]  B. Spiegelman,et al.  15-Deoxy-Δ 12,14-Prostaglandin J 2 is a ligand for the adipocyte determination factor PPARγ , 1995, Cell.

[5]  J. Berger,et al.  Potentiation of insulin stimulation of phosphatidylinositol 3-kinase by thiazolidinedione-derived antidiabetic agents in Chinese hamster ovary cells expressing human insulin receptors and L6 myotubes. , 1994, The Journal of biological chemistry.

[6]  F. Lönnqvist,et al.  Overexpression of the obese (ob) gene in adipose tissue of human obese subjects , 1995, Nature Medicine.

[7]  J. Lehmann,et al.  A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation , 1995, Cell.

[8]  J. Colca,et al.  New Oral Thiazolidinedione Antidiabetic Agents Act as Insulin Sensitizers , 1992, Diabetes Care.

[9]  M. Karin,et al.  Negative transcriptional regulation by nuclear receptors. , 1994, Seminars in cancer biology.

[10]  R. Evans,et al.  Cross-coupling of signal transduction pathways: zinc finger meets leucine zipper. , 1991, Trends in genetics : TIG.

[11]  P. Traber,et al.  The human sucrase-isomaltase gene directs complex patterns of gene expression in transgenic mice. , 1993, The American journal of physiology.

[12]  R. Kletzien,et al.  Localization of a pioglitazone response element in the adipocyte fatty acid-binding protein gene. , 1994, Molecular pharmacology.

[13]  R. Ulrich,et al.  Enhancement of adipocyte differentiation by an insulin-sensitizing agent. , 1992, Molecular pharmacology.

[14]  R. Pollet,et al.  Regulation of glucose transport by pioglitazone in cultured muscle cells. , 1994, Metabolism: clinical and experimental.

[15]  B. Spiegelman,et al.  Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor , 1994, Cell.

[16]  R. Considine,et al.  Serum immunoreactive-leptin concentrations in normal-weight and obese humans. , 1996, The New England journal of medicine.

[17]  Steven L. Cohen,et al.  Weight-reducing effects of the plasma protein encoded by the obese gene. , 1995, Science.

[18]  J. Bismuth,et al.  Developmental and thyroidal regulation of the nuclear T3 receptors/c-erb A oncogene products in the Ob 17 preadipocyte cell line. , 1991, Journal of receptor research.

[19]  B. Spiegelman,et al.  mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. , 1994, Genes & development.

[20]  M. Cawthorne,et al.  Treatment with the thiazolidinedione (BRL 49653) decreases insulin resistance in obese Zucker hindlimb. , 1995, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[21]  O. MacDougald,et al.  Regulated expression of the obese gene product (leptin) in white adipose tissue and 3T3-L1 adipocytes. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. Lazar.  Thyroid hormone receptors: multiple forms, multiple possibilities. , 1993, Endocrine reviews.

[23]  M. Pfahl.  Nuclear receptor/AP-1 interaction. , 1993, Endocrine reviews.

[24]  R. Devos,et al.  Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. , 1995, Science.

[25]  S. Mandrup,et al.  Transcriptional activation of the mouse obese (ob) gene by CCAAT/enhancer binding protein alpha. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[26]  B. Spiegelman,et al.  PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene , 1995, Molecular and cellular biology.

[27]  J. Friedman,et al.  Expression of ob Gene in Adipose Cells , 1996, The Journal of Biological Chemistry.

[28]  R. Considine,et al.  Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity. , 1995, The Journal of clinical investigation.

[29]  M. Lazar,et al.  Peroxisome proliferator and retinoid signaling pathways co-regulate preadipocyte phenotype and survival. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. Lehmann,et al.  An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ) (*) , 1995, The Journal of Biological Chemistry.

[31]  M. Quon,et al.  The Mouse obese Gene , 1995, The Journal of Biological Chemistry.

[32]  K. Umesono,et al.  Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Kai Yu,et al.  Differential Activation of Peroxisome Proliferator-activated Receptors by Eicosanoids (*) , 1995, The Journal of Biological Chemistry.

[34]  J. Auwerx,et al.  Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates. , 1995, The Journal of clinical investigation.

[35]  M. Deitel,et al.  Increased obese mRNA expression in omental fat cells from massively obese humans , 1995, Nature Medicine.

[36]  M. Lazar,et al.  Induction of Rev-ErbA alpha, an orphan receptor encoded on the opposite strand of the alpha-thyroid hormone receptor gene, during adipocyte differentiation. , 1993, The Journal of biological chemistry.

[37]  B. Ludvik,et al.  Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. , 1994, The New England journal of medicine.

[38]  K. Umesono,et al.  The nuclear receptor superfamily: The second decade , 1995, Cell.

[39]  E. Ravussin,et al.  Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects , 1995, Nature Medicine.

[40]  J. Auwerx,et al.  Transient increase in obese gene expression after food intake or insulin administration , 1995, Nature.

[41]  J. Friedman,et al.  Increased expression in adipocytes of ob RNA in mice with lesions of the hypothalamus and with mutations at the db locus. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[42]  M. Pelleymounter,et al.  Effects of the obese gene product on body weight regulation in ob/ob mice. , 1995, Science.